Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, and the Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, Mass (Dr Choudhry); the Departments of Medicine and Health Policy, Management and Evaluation, University of Toronto, and the Department of Medicine, Mount Sinai Hospital and University Health Network, Toronto, Ontario (Dr Detsky).
Corresponding Author: Niteesh K. Choudhry, MD, FRCPC, Brigham and Women's Hospital, 1620 Tremont St, Suite 3030, Boston, MA 02120 ([email protected]).
Funding/Support: Dr Choudhry is funded by a Pharmaceutical Policy Research Fellowship from Harvard Medical School and a Canadian Institutes of Health Research postdoctoral fellowship. Neither of the authors has any financial conflicts of interest related to this article.
Role of the Sponsors: The funding agencies had no role in the conception, conduct, data collection, analysis, interpretation, writing, or approval of this article.
Acknowledgment: We are grateful to Joseph Newhouse, PhD, Robert Evans, PhD, Sujit Choudhry, LLB, LLM, Meredith A. Goldwasser, ScD, and Allen Kachalia, MD, JD, for helpful comments.
